ALINT Stock Chart & Stats
€0.14
€0.00(0.00%)
At close: 4:00 PM EST
€0.14
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.12 - €0.36
Previous CloseN/A
Volume7.83K
Average Volume (3M)18.21K
Market Cap
€1.24M
Enterprise Value€478.32K
Total Cash (Recent Filing)€1.11M
Total Debt (Recent Filing)€305.00K
Price to Earnings (P/E)―
Beta-0.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,727,332
10 Day Avg. Volume17,672
30 Day Avg. Volume18,207
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.98
Price to Sales (P/S)0.18
P/FCF Ratio-0.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ALINT FAQ
What was IntegraGen SA’s price range in the past 12 months?
IntegraGen SA lowest stock price was €0.12 and its highest was €0.36 in the past 12 months.
What is IntegraGen SA’s market cap?
IntegraGen SA’s market cap is €1.24M.
When is IntegraGen SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were IntegraGen SA’s earnings last quarter?
Currently, no data Available
Is IntegraGen SA overvalued?
According to Wall Street analysts IntegraGen SA’s price is currently Overvalued.
Does IntegraGen SA pay dividends?
IntegraGen SA does not currently pay dividends.
What is IntegraGen SA’s EPS estimate?
IntegraGen SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IntegraGen SA have?
IntegraGen SA has 6,727,332 shares outstanding.
What happened to IntegraGen SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of IntegraGen SA?
Currently, no hedge funds are holding shares in FR:ALINT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IntegraGen SA
IntegraGen S.A. provides advanced human genome analysis services to academic researchers and life science businesses across France. Their comprehensive genomic offerings include transcriptomics, epigenomics, DNA sequencing, next-generation sequencing (NGS) specifically for cancer research, and SNP genotyping. The company also delivers clinical research solutions, such as clinical-grade sequencing and pharmacogenomic studies, in addition to supporting fundamental human genetic investigations. For agricultural applications, IntegraGen offers agrigenomic services covering crop and livestock genotyping, as well as high-throughput sequencing for these domains. Their microbial genomics division conducts whole-genome microbial sequencing and transcriptomics. IntegraGen further develops a suite of sophisticated bioinformatics tools: MERCURY is an online platform for oncology, designed to transform raw high-throughput sequencing data into molecular reports for translational and clinical research. SIRIUS, a cloud-based software, empowers researchers to analyze whole genome, whole exome, and gene panel sequencing information. Galileo is another cloud application that enables dynamic exploration of RNA-Seq expression data. Finally, GeCo, their genomic consulting service, provides researchers access to expert biostatisticians and bioanalysts. Founded in 2000 and headquartered in Évry, France, IntegraGen S.A. is a subsidiary of OncoDNA SA.
Technical Analysis
Nanobiotix
―
Transgene
―
GenSight Biologics SA
―
Cellectis SA
―
Hybrigenics SA Class A
―